Achyut Healthcare Ltd

AI
Achyut Healthcar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Achyut Healthcare Ltd

₹ 8.09 -0.61%
09 Nov - close price
achyuthealthcare.com BSE: 543499
About

Achyut Healthcare Ltd (formerly Achyut Healthcare
Pvt Ltd; originally Achyut Securities Pvt Ltd) is an Ahmedabad-based trader in APIs, pharmaceutical products/inputs and medical devices. It is developing
a formulations plant at Bhat, Ahmedabad.[1][2]

Key Points

Current vs legacy business:[1]
The operating business remains trading/dealing in APIs and pharmaceutical products; In FY26 accounts classify purchases as “traded goods”. The company entered pharma trading in 2015 after its earlier securities-company history.[2]

Website BSE
  • Market Cap ₹ 195 Cr.
  • Current Price ₹ 8.09
  • High / Low ₹ 10.0 / 4.70
  • Stock P/E 781
  • Book Value ₹ 1.46
  • Dividend Yield 0.00 %
  • ROCE 1.18 %
  • ROE 0.96 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Debtor days have improved from 76.8 to 45.7 days.
  • Company's working capital requirements have reduced from 515 days to 91.0 days

Cons

  • Stock is trading at 5.54 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 1.53% over last 3 years.
  • Promoter holding has decreased over last 3 years: -6.37%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
0.00 0.92 3.09 2.55 1.57 4.39 3.13 1.66
0.13 0.87 3.02 2.41 1.58 4.37 2.95 1.63
Operating Profit -0.13 0.05 0.07 0.14 -0.01 0.02 0.18 0.03
OPM % 5.43% 2.27% 5.49% -0.64% 0.46% 5.75% 1.81%
0.18 0.18 0.08 0.11 0.04 0.14 0.05 0.09
Interest 0.00 0.04 0.01 0.01 0.00 0.03 0.01 0.01
Depreciation 0.00 0.06 0.03 0.03 0.03 0.08 0.03 0.04
Profit before tax 0.05 0.13 0.11 0.21 0.00 0.05 0.19 0.07
Tax % 20.00% 7.69% 9.09% 33.33% 0.00% 26.32% 28.57%
0.03 0.12 0.10 0.14 0.00 0.06 0.14 0.05
EPS in Rs 0.00 0.01 0.00 0.01 0.00 0.00 0.01 0.00
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
0.67 0.33 0.27 4.05 2.70 6.14 3.05 11.59 10.75
0.66 0.32 0.26 4.08 2.97 6.12 3.20 11.42 10.53
Operating Profit 0.01 0.01 0.01 -0.03 -0.27 0.02 -0.15 0.17 0.22
OPM % 1.49% 3.03% 3.70% -0.74% -10.00% 0.33% -4.92% 1.47% 2.05%
0.00 0.01 0.00 0.14 0.59 0.73 0.92 0.38 0.32
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.04 0.05
Depreciation 0.00 0.00 0.00 0.01 0.01 0.01 0.08 0.14 0.18
Profit before tax 0.01 0.02 0.01 0.10 0.31 0.74 0.65 0.37 0.31
Tax % 300.00% 0.00% 0.00% 60.00% 25.81% 32.43% 21.54% 16.22%
-0.01 0.01 0.01 0.04 0.23 0.50 0.51 0.32 0.25
EPS in Rs -0.01 0.01 0.01 0.00 0.01 0.02 0.02 0.01 0.01
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 112%
3 Years: 63%
TTM: 64%
Compounded Profit Growth
10 Years: %
5 Years: 100%
3 Years: 12%
TTM: -36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 25%
1 Year: 50%
Return on Equity
10 Years: %
5 Years: 2%
3 Years: 2%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 0.25 0.25 0.25 6.74 9.35 16.83 23.56 24.14 24.14
Reserves -0.05 -0.04 0.00 2.34 5.18 13.93 7.71 10.93 11.12
0.00 0.00 0.00 0.00 0.00 0.00 1.55 1.49 0.27
0.04 0.06 0.25 0.86 0.81 0.19 1.30 1.54 4.49
Total Liabilities 0.24 0.27 0.50 9.94 15.34 30.95 34.12 38.10 40.02
0.00 0.00 0.00 0.03 0.05 0.06 1.44 1.55 1.52
CWIP 0.00 0.00 0.00 0.00 3.49 9.16 18.29 27.88 31.62
Investments 0.00 0.00 0.00 1.70 1.30 0.00 0.00 0.00 0.00
0.24 0.27 0.50 8.21 10.50 21.73 14.39 8.67 6.88
Total Assets 0.24 0.27 0.50 9.94 15.34 30.95 34.12 38.10 40.02

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.03 -0.02 0.01 -6.96 -0.43 -0.36 -4.00 1.13
0.00 0.00 0.00 -1.60 -4.81 -15.23 -1.50 -2.23
0.00 0.00 0.00 8.79 5.21 15.72 -0.14 3.38
Net Cash Flow -0.03 -0.02 0.01 0.24 -0.03 0.14 -5.64 2.29
Free Cash Flow -0.03 -0.02 0.01 -6.99 -3.75 -6.37 -14.79 -7.15
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -300% -100% 100% 23,100% 126% -700% 2,553% 712%

Ratios

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 54.48 188.03 378.52 18.02 36.50 24.37 160.36 45.66
Inventory Days 0.00 0.00 158.70 14.29 59.59 3.96 24.16 15.79
Days Payable 380.87 41.78 55.87 12.54 144.98 44.43
Cash Conversion Cycle 54.48 188.03 156.34 -9.46 40.22 15.79 39.54 17.02
Working Capital Days 76.27 210.15 216.30 603.83 1,257.22 1,242.43 210.62 91.01
ROCE % 9.76% 4.35% 2.14% 2.63% 3.27% 2.17% 1.18%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export sales as % of revenue from operations
%

Log in to view insights

Please log in to see hidden values.

Login
Number of permanent employees on rolls
employees

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Apr 2023Sep 2023Mar 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
53.77% 53.77% 44.80% 46.11% 46.11% 46.11% 46.37% 47.07% 47.71% 47.40% 47.40% 47.40%
0.00% 0.00% 0.00% 6.14% 8.15% 8.15% 6.14% 5.26% 5.26% 5.13% 5.13% 5.13%
46.22% 46.24% 55.20% 47.76% 45.75% 45.75% 47.49% 47.67% 47.02% 47.47% 47.47% 47.47%
No. of Shareholders 1621671791934715245415655141,9053,1743,925

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP